Surfactant effects on aerosolized and instilled adenoviral-mediated gene transfer

Human Gene Therapy

Volumn 7, Issue 6, 1996, Pages 697-704

  Jobe, Alan H ^a   Ikegami, Machiko ^a   Yei, Soonpin ^c   Whitsett, Jeffrey A ^b   Trapnell, Bruce ^c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; PHOSPHORUS; SULFUR; SURFACTANT; TECHNETIUM 99M; TRITIUM;

ADENOVIRUS; AEROSOL; AIRWAY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHUS; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; GENE TRANSFER; HUMAN; LUNG PARENCHYMA; NONHUMAN; PARTICLE SIZE; RABBIT; TRACHEA; TRANSGENE;

EID: 0029868011     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.6-697     Document Type: Article

References (22)

1. BRAIN, J.D., KNUDSON, D.E., SOROKIN, S.D., and DAVIS, M.A. (1976). Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation. Environ. Res. 11, 13-33.
2. BRASIER, A.R., TATE, J.E., and HABENER, J.F. (1989). Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. BioTechniques 7, 1116-1122.
3. CANONICO, A.E., CONARY, J.T., MEYRICK, B.O., and BRIGHAM, K.L. (1994). Aerosol and intravenous transfection of human α1-antitrypsin gene to lungs of rabbits. Am. J. Respir. Cell Mol. Biol. 10, 24-29.
4. CONLON, K.C., CORBALLY, M.T., BADING, J.R., and BRENNAN, M.F. (1990). Atraumatic endotracheal intubation in small rabbits. Lab. Anim. Sci. 40, 221-222.
5. DAVIS, J.M., RUSS, G.A., METLAY, L., DICKERSON, B., and GREENSPAN, B.S. (1992). Short-term distribution kinetics of intratracheally administered exogenous lung surfactant. Pediatr. Res. 31, 445-450.
6. JOBE, A.H. (1995). Techniques for administering surfactant. In Surfactant Therapy for Lung Disease. B. Robertson and H.W. Taeusch, eds. (Marcel Dekker, New York) pp. 309-324.
7. JOBE, A.H., IKEGAMI, M., UEDA, T., PURTEL, J., WERT, S., WHITSETT, J.A., and TRAPNELL, B.C. (1995). Enhancement of adenoviral-mediated gene transfer with surfactant. Am. J. Respir. Crit. Care Med. 151, A671.
8. KHARASCH, V.S., SWEENEY, T.D., FREDBERG, J., LEHR, J., DAMOKOSH, A.I., AVERY, M.E., and BRAIN, J.D. (1991). Pulmonary surfactant as a vehicle for intratracheal delivery of technetium sulfur colloid and pentamidine in hamster lungs. Am. Rev. Respir. Dis. 144, 909-913.
9. LEWIS, J.F., and McCAIG, L. (1993). Aerosolized versus instilled exogenous surfactant in a nonuniform pattern of lung injury. Am. Rev. Respir. Dis. 148, 1187-1193.
10. LEWIS, J., IKEGAMI, M., HIGUCHI, R., JOBE, A., and ABSOLOM, D. (1991). Nebulized vs. Instilled exogenous surfactant in an adult lung injury model. J. Appl. Physiol. 7, 1270-1276.
11. LEWIS, J., IKEGAMI, M., JOBE, A.H., and ABSOLOM, D. (1993). Physiologic responses and distribution of aerosolized surfactant (Survanta®) in a nonuniform pattern of lung injury. Am. J. Respir. Dis. 147, 1364-1370.
12. MASTRANGELI, A., DANEL, C., ROSENFELD, M.A., STRATFORD-PERRICAUDET, M.L., PERRICAUDET, M., PAVIRANI, A., LECOCQ, J-P., and CRYSTAL, R.G. (1993). Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. Clin. Invest. 91, 225-234.
13. MITTEREDER, N., YEI, S., BACHURSKI, C., CUPPOLETTI, J., WHITSETT, J.A., TOLSTOSHEV, P., and TRAPNELL, B.C. (1994). Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5, 717-729.
14. MIZUNO, K., IKEGAMI, M., CHEN, C-M., UEDA, T., and JOBE, A.H. (1995). Surfactant protein-B supplementation improves in vivo function of a modified natural surfactant. Pediatr. Res. 37, 271-276.
15. O'RIORDAN, T.G., GRECO, M.J., PERRY, R.J., and SMALDONE, G.C. (1992). Nebulizer function during mechanical ventilation. Am. Rev. Respir. Dis. 145, 1117-1122.
16. RAABE, O.G. (1984). Deposition and clearance of inhaled particles. In Occupational Lung Diseases. J.B.L. Gee, W.K.C. Morgan, and S.M. Brooks, eds. (Raven, New York) pp. 1-38.
17. ROSENFELD, M.A., YOSHIMURA, K., TRAPNELL, B.C., YONEYAMA, K., ROSENTHAL, E.R., DALEMANS, W., FUKAYAMA, M., BARGON, J., STIER, L.E., STRATFORD-PERRICAUDET, L., PERRICAUDET, M., GUGGINO, B.W., PAVIRANI, A., LECOCQ, J-P., and CRYSTAL, R.G. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155.
18. STRIBLING, R., BRUNETTE, E., LIGGITT, D., GAENSLER, K., and DEBS, R. (1992). Aerosol gene delivery in vivo. Proc. Natl. Acad. Sci. USA 89, 11277-11281.
19. TAEUSCH, H. W., KEOUGH, K.M.W., WILLIAMS, M., SLAVIN, R., STEELE, E., LEE, A.S., PHELPS, D., KARIEL, N., FLOROS, J., and AVERY, M.E. (1986). Characterization of bovine surfactant for infants with respiratory distress syndrome. Pediatrics 77, 572-581.
20. WOLLMER, P., JONSON, B., and LACHMAN, B. (1995). Evaluation of lung permeability in neonatal and adult respiratory distress syndrome. In Surfactant Therapy for Lung Disease. B. Robertson and H.W. Taeusch, eds. (Marcel Dekker, New York) pp. 199-213.
21. YEI, S., MITTEREDER, N., TANG, K., O'SULLIVAN, C., and TRAPNELL, B.C. (1994). Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther. 1, 192-200.
22. ZSENGELLER, A.K., WERT, S.E., HULL, W.M., HU, X., YEI, S., TRAPNELL, B.C., and WHITSETT, J.A. (1995). Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6, 457-467.